However, reports of bradycardia occurring with a low dose of tizanidine (2 mg) in the absence of drug interactions, metabolic disorders, structural cardiac conditions, or abrupt cessation of smoking an action known to decrease CYP1A2 enzyme activity potentially are exceptionally uncommon [12]. Here, CYP1A2 is linked to metabolic disease.